Facebook
Twitter
LinkedIn
ForwardSupportive Care Interventions: A Focus on Treatment-Related Complications of the Oral Cavity and Oropharynx
This educational activity will focus on the identification and management of oral and swallowing complications caused by cancer-directed therapy for patients with head and neck cancer.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Apply best available evidence for management of oral complications caused by cancer-directed therapy for HNSCC by utilizing MASCC/ISOO and ASCO guidelines.
- Recognize devices, drugs and drug mechanisms that are furthest along in trial development for management of oral mucositis.
- Describe the 4 fundamentals of Oral Care in head and neck cancer patients.
- Gain access to clinical practice tools to enhance communication with patients and colleagues chairside.
- Identify potential dysphagia complications related to immunotherapy, understand the importance of PROMS and clinical measures to quantify these complications and collaborate closely with the multidisciplinary care team.
Assuntina Sacco, MD, is employed by the University of California, San Diego and has no financial relationships with a commercial interest.
Carryn Anderson, MD, is employed by the University of Iowa and Heartland Anesthesia. She serves on the advisory board of AANA and is a consultant for Galera Therapeutics, Inc. She has a leadership with University of Iowa Hospitals and Clinics.
Deborah Saunders, DMD, is employed by the Northeast Cancer Center, Health Sciences North and receives research funding from Meira GTx. She receives honoraria and travel expenses from Merck.
Kristen Linnemeyer, SLP, is employed by the University of California, San Diego and has no financial relationships with a commercial interest.
All relevant relationships have been mitigated.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
Available Credit
- 0.75 AMA PRA Category 1 Credit™The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 0.75 Certificate of AttendanceThis activity was designated for 0.75 AMA PRA Category 1 Credit™.